Mechanism of action of celecoxib on normal and acid-challenged gastric mucosa

Experimental and Toxicologic Pathology

Volumn 61, Issue 4, 2009, Pages 353-361

  Dutta, Nisha ^a   Sarotra, Pooja ^a   Gupta, Shikha ^a   Aggarwal, Ritu ^b   Agnihotri, Navneet ^a  

^a PANJAB UNIVERSITY   (India)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Celecoxib; Gastric mucosa; Oxidative stress; Reactive oxygen species

Indexed keywords

CATALASE; CELECOXIB; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HYDROCHLORIC ACID; MALONALDEHYDE; NITRITE; SUPEROXIDE DISMUTASE; THIOL DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; ENZYME ACTIVITY; GASTRITIS; HISTOPATHOLOGY; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; STOMACH INJURY; STOMACH MUCOSA; STOMACH MUCUS;

ANIMALS; CATALASE; CYCLOOXYGENASE 2 INHIBITORS; GASTRIC MUCOSA; GASTRITIS; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HYDROCHLORIC ACID; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; NITRITES; PYRAZOLES; RATS; RATS, WISTAR; SULFHYDRYL COMPOUNDS; SULFONAMIDES; SUPEROXIDE DISMUTASE;

RATTUS NORVEGICUS;

EID: 67249124493     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etp.2008.10.003     Document Type: Article

References (55)

1. Agnihotri N., Kaur H., Kaur N., and Sarotra P. Role of oxidative stress in lansoprazole-mediated gastric and hepatic protection in Wistar rats. Indian J Gastroenterol 26 3 (2007) 118-121
2. Berenguer B., Alarcón De La Lastra C., Motilva V., La Casa C., Herrerias J.M., Pozo D., et al. Effects of celecoxib on acid-challenged gastric mucosa of rats: comparison with metamizol and piroxicam. Dig Dis Sci 49 6 (2004) 937-947
3. Betteridge D.J. What is oxidative stress?. Metabolism 49 (2000) 3-8
4. Blandizzi C., Fornai M., Colucci R., Natale G., Lubrano V., Vassalle C., et al. Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage. World J Gastroenterol 11 26 (2005) 4052-4060
5. Blandizzi V., Natale G., Gheradi G., Lazzeri G., Marveggio C., Colucci R., et al. Acid independent gastroprotective effects of lansoprazole in experimental mucosal injury. Dig Dis Sci 44 10 (1999) 2039-2050
6. Brown J.F., Keates A.C., Hanson P.J., and Whittle B.J. Nitric oxide generators and cGMP stimulate mucus secretion by rat gastric mucosal cells. Am J Physiol 265 3Pt 1 (1993) G418-G422
7. Corne S.J., Morrissey S.M., and Woods R.J. Proceedings: a method for the quantitative estimation of gastric barrier mucus. J Physiol 242 2 (1974) 116P-117P
8. Dharmani P., Kumar K.V., Srivastava S., and Palit G. Ulcer healing effect of anti-ulcer agents. A comparative study. Internet J Acad Physicians Assistants 3 2 (2003) 1092-4078
9. Ellman G.L. Tissue sulfydryl groups. Arch Biochem Biophys 82 1 (1959) 70-77
10. Frei B., Stocker R., and Ames B.N. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci USA 85 24 (1988) 9748-9752
11. Galunska B., Marazova K., Tankova T., Popov A., Frangov P., Krushkov I., et al. Effects of paracetamol and proparacetamol on gastric mucosal damage and gastric lipid peroxidation caused by acetylsalicylic acid (ASA) in rats. Pharmacol Res 46 2 (2002) 141-147
12. Gotta A.W. Valdecoxib (pharmacia). Curr Opin Investig Drugs 3 2 (2002) 240-245
13. Gracy R.W., Talent J.M., Kong Y., and Conrad C.C. Reactive oxygen species: the unavoidable environmental insult. Mutat Res 428 1 (1999) 17-22
14. 15N] nitrate in biological fluids. Anal Biochem 126 1 (1982) 131-138
15. Gretzer B., Maricic N., Respondek M., Schuligoi R., and Peskar B.M. Effects of specific inhibition of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the rat stomach with normal mucosa and after acid challenge. Br J Pharmacol 132 7 (2001) 1565-1573
16. Gupta S., Sarotra P., Aggarwal R., Dutta N., and Agnihotri N. Role of oxidative stress in celecoxib-induced renal damage in Wistar rats. Dig Dis Sci 52 11 (2007) 3092-3098
17. Habig W., Pabst M.J., and Jackboy W.B. Glutathione-S-transferase: the first enzymatic step in mercapturic acid formation. J Biol Chem 249 22 (1974) 7130-7139
18. Hassan A., Martin E., and Puig-Parellada P. Role of antioxidants in gastric mucosal damage induced by indomethacin in rats. Methods Find Exp Clin Pharmacol 20 10 (1998) 849-854
19. Hawkey C.J. COX-2 inhibitors. Lancet 353 9149 (1999) 307-314
20. Herbenick M.A., Sprott D., Stills H., and Lawless M. Effects of a cyclooxygenase 2 inhibitor on fracture healing in a rat model. Am J Orthop 37 7 (2008) E133-E137
21. Kawamori T., Rao C.V., Seibert K., and Reddy B.S. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res 58 3 (1998) 409-412
22. Kirkova M., Kesiova M., Konstantinova S., Alexandrova A., Petrov L., Tsvetanova E., et al. In vivo effects of amtolmetin guacyl on lipid peroxidation and antioxidant defence systems in different models of gastrointestinal injury. Auton Autacoid Pharmacol 27 1 (2007) 63-70
23. Kono Y. Generation of superoxide radicals during auto-oxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochem Biophys 186 (1978) 189-195
24. Laudanno O.M., Cesolari J.A., Esnarriaga J., Rista L., Piombo G., Maglione C., et al. Gastrointestinal damage induced by celecoxib and refecoxib in rats. Dig Dis Sci 46 4 (2001) 779-784
25. Le Q.L., Zhang J., Xu Q.Z., and Gao H.Y. Role of nitric oxide in omeprazole protection of the gastric mucosa in rats. Di Yi Jun Yi Da Xue Xue Bao 21 12 (2001) 926-928
26. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with Folin phenol reagent. J Biol Chem 193 1 (1951) 265-275
27. Luck H. Catalase. In: Bergmeyer H.U. (Ed). Methods of enzymatic analysis (1963), Academic Press, New York, London
28. Manjari V., and Das U.N. Oxidant stress, anti-oxidants, nitric oxide and essential fatty acids in peptic ulcer disease. Prostaglandins Leukot Essent Fatty Acids 59 6 (1998) 401-406
29. Mimic-Oka J., Simic T., Djukanovic L., Reljic Z., and Davicevic Z. Alteration in plasma antioxidant capacity in various degrees of chronic renal failure. Clin Nephrol 51 4 (1999) 233-241
30. Mizuno H., Sakomoto C., Matsuda K., Wada K., Uchida T., Noguchi H., et al. Induction of cyclooxygenase 2 in gastric mucosa lesions and its inhibition by specific antagonist delays healing in mice. Gastroenterology 112 2 (1997) 645-648
31. Naito Y., Yoshikawa T., Yoshida N., and Kondo M. Role of oxygen radical and lipid peroxidation in indomethacin induced gastric injury. Dig Dis Sci 43 9 (1998) 30S-34S
32. Natale G., Lazzeri G., Lubrano V., Colucci R., Vassalle C., Fornai M., et al. Mechanisms of gastroprotection by lansoprazole pretreatment against experimentally induced injury in rats: role of mucosal oxidative damage and sulfhydryl compounds. Toxicol Appl Pharmacol 195 1 (2004) 62-72
33. Ohta Y., and Nishida K. Protective effect of coadministered superoxide dismutase and catalase against stress-induced gastric mucosal lesions. Clin Exp Pharmacol Physiol 30 8 (2003) 545-550
34. Penissi A.B., and Piezzi R.S. Effect of dehydroleucodine on mucus production. A quantitative study. Dig Dis Sci 44 4 (1999) 708-712
35. Peskar B.M., Maricic N., Gretzera B., Schuligoi R., and Schmassmann A. Role of cyclooxygenase-2 in gastric mucosal defense. Life Sci 69 25-26 (2001) 2993-3003
36. Sanchez S., Martin M.J., Ortiz P., Motilva V., and Alarcon de la Lastra C. Effects of dipyrone on inflammatory infiltration and oxidative metabolism in gastric mucosa: comparison with acetaminophen and diclofenac. Dig Dis Sci 47 6 (2002) 1389-1398
37. Sawaoka H., Tsuji S., Tsujii M., Gunawan E.S., Nakama A., Takei Y., et al. Expression of cyclooxygenase-2 gene in gastric epithelium. J Clin Gastroenterol 25 1 (1997) S105-S110
38. Schmassmann A., Peskar B.M., Stettler C., Netzer P., Stroff T., Flogerzi B., et al. Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats. Br J Pharmacol 123 5 (1998) 795-804
39. Sedlak J., and Lindsay R.H. Estimation of total, protein bound and nonprotein bound sulfhydryl groups in tissues with Ellman's reagent. Anal Biochem 25 1 (1968) 192-205
40. Sener-Muratoglu G., Paskaloglu K., Arbak S., Hurdag C., and Ayanoglu-Dulger G. Protective effects of famotidine, omeprazole and melatonin against acetylsalicylic acid-induced gastric damage in rats. Dig Dis Sci 46 2 (2001) 318-330
41. Smalley W.E., Ray W.A., Daugherty J.R., and Griffin M.R. Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons. Am J Epidemiol 141 6 (1995) 539-545
42. Sun W.H., Tsuji S., Tsujii M., Gunawan E.S., Sawaoka H., Kawai N., et al. Cyclo-oxygenase-2 inhibitors suppress epithelial cell kinetics and delay gastric wound healing in rats. J Gastroenterol Hepatol 15 7 (2000) 752-761
43. Tandon R., Khanna H.D., Dorababu M., and Goel R.K. Oxidative stress and antioxidants status in peptic ulcer and gastric carcinoma. Ind J Physiol Pharmacol 48 1 (2004) 115-118
44. Tepperman B.L., and Jacobson E.D. Circulatory factors in gastric mucosal defense and repair. In: Johnson L.R. (Ed). Physiology of the gastrointestinal tract. 3 ed. (1994), Raven Press, New York 1331-1351
45. Vane J.R. Inhibition of prostaglandin synthesis as a mechanism of action of aspirin like drugs. Nat New Biol 231 25 (1971) 232-235
46. Villegas I., Marti{dotless}n M.J., La Casa C., Motilva V., and De La Lastra C.A. Effects of oxicam inhibitors of cyclooxygenase on oxidative stress generation in rat gastric mucosa. A comparative study. Free Radic Res 36 7 (2002) 769-777
47. Wallace J.L. Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years. Gastroenterology 112 3 (1997) 1000-1016
48. Wallace J.L. COX-2: a pivotal enzyme in mucosal protection and resolution of inflammation. Sci World J 6 (2006) 577-588
49. Wallace J.L., and Granger D.N. The cellular and molecular basis of gastric mucosal defense. FASEB J 10 7 (1996) 731-740
50. Wallace J.L., McKnight W., Reuter B.K., and Vergnolle N. NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2. Gastroenterology 119 3 (2000) 706-714
51. Warner T.D., and Mitchell J.A. Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic. FASEB J 18 7 (2004) 790-804
52. Whittle B.J. COX-1 and COX-2 products in the gut: therapeutic impact of COX-2 inhibitors. Gut 47 3 (2000) 320-325
53. Whittle B.J.R. Nitric oxide in gastrointestinal physiology. In: Johnson L.R. (Ed). Physiology of the gastrointestinal tract. 3 ed. (1994), Raven Press, New York 267-294
54. Wills E.D. Lipid peroxide formation in microsomes. Relationship of hydroxylation to lipid peroxidation. Biochem J 113 2 (1969) 333-341
55. Yoshikawa T., Minamiyama Y., Ichikawa H., Takahashi S., Naito Y., and Kondo M. Role of lipid peroxidation and antioxidant in gastric mucosal injury induced by the hypoxanthine-xanthine oxidase system in rats. Free Radic Biol Med 23 2 (1997) 243-250